TheProfitWatch

BNTC - Benitec Biopharma Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
15.08 0.8 (5.31%) --- --- --- --- 0.8 (5.31%) --- ---

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.24
Diluted EPS:
-0.24
Basic P/E:
-66.1667
Diluted P/E:
-66.1667
RSI(14) 1m:
65.52
VWAP:
15.88
RVol:
1.0002

Events

Period Kind Movement Occurred At
10m Price decrease 10m 14.59 -0.49 (-3.24%) Oct 15 09:31

Related News